solubility of Efavirenz (Efv), which belongs to BCS class II. Efv is non neucleotide reverse transcriptase inhibitor (NNRTI) for first line antiretroviral treatment type 1 with long half life
absent in Scpa-ETFB, the signature sequences of the ETF superfamily were identified. Using reverse transcriptase polymerase chain reaction, we detected the messenger RNA transcript of Scpa-ETFB in high
sample was subjected to RNA extraction and the other part was not, before performing reverse transcriptase (RT)-PCR. The assay succeeded to type BVDV with and without extraction
high proliferative potential, the migratory and homing (?invasiveness?) capabilities, telomere length, telomerase and reverse transcriptase activity and gene expression are only a few of biological characteristic or…
with aqueous solubility 4 μg/mL and oral bioavailability 40-45%, having non-nucleoside reverse transcriptase inhibitor (NNRTI) antiretroviral activity. The aim of the present study was to develop
Nevirapine is a non–nucleoside Reverse Transcriptase inhibitor, antiviral agent. A simple, selective, and sensitive high performance liquid chromatography method for the determination of Nevirapine in human plasma was…
product acceptance from a Phase I clinical trial of a candidate non-nucleoside reverse transcriptase inhibitor (NNRTI) vaginal microbicide product (UC781). The product was evaluated in the context
line-treatment basis in HIV-1 infected children is a combination of 2 nucleoside reverse transcriptase inhibitors and 1 protease inhibitor or 1 non NRTI. However, after few months
combination with compounds of four different classes of antiretroviral drugs (entry inhibitors, reverse transcriptase inhibitors, integrase inhibitors and protease inhibitors)in cell-cell HIV transmission routes and…
Tenofovir disproxil fumarate belongs to class of anti-retroviral drugs known as nucleotide analogue reverse transcriptase inhibitors. The main objective of the present study is to formulate and evaluate
disease of proximal renal tubule with inherited or acquired etiology. Nucleotide reverse transcriptase inhibitors (NtRTIs) are well known causes of this entity. Tenofovir is one of the safest drug
cytogenetic analysis either by conventional Karyotyping, FISH (fluorescence in situ hybridization) and RT-PCR (Reverse transcriptase polymerase chain reaction). The antigen expressions by immunophenotype in acute…
reverse transcriptase telomerase is one of the hallmarks of cancer and an excellent candidate for targeting cancer. Imetelstat is a potent inhibitor of telomerase with demonstrated anti-tumor eff ects
seven and analyzed using osteogenesis cDNA gene array. The selected genes were verified using reverse transcriptase (RT)-PCR analysis. Human periosteal cells differentiated along an osteogenic lineage after treatment
antiviral therapy is mainly focusing on blocking the function of viral proteins, such as Reverse Transcriptase, Protease, or Integrase, to treat AIDS patients. Although the intended purpose of antiviral drugs
were investigated, including 217 nucleos(t)ide analog-experienced patients. HBV genotypes/subgenotypes and reverse transcriptase (RT) mutations were determined by direct sequencing. Th e stage of fi brosis
respectively. Anti-HIV activity was assessed based on inhibition of р24 protein concentration and reverse transcriptase (RT) activity. It was shown that the drug administered once 24 hours prior
clinical strains. The SMART (switching mechanism at 5ꞌ end of RNA template of reverse transcriptase) technique was used to construct a full-length cDNA library of an HCMV clinical strain
Telomerase, a ribonucleoprotein with reverse transcriptase activity, enables human cells to maintain chromosomal stability and to proliferate without limits. Various studies demonstrated telomerase activation in human…
Background: Nucleoside reverse-transcriptase inhibitors (NRTIs) are a major component of combination antiretroviral therapy (cART) worldwide but they have been associated with mitochondrial toxicities, with one of the…
PURPOSE: Tenofovir disoproxil Fumarate (TDF) is a Nucleoside Reverse Transcriptase Inhibitor (NRTI) used in the management of HIV/AIDS. The drug has not been listed in the Official Pharmacopoeias
peripheral blood mononuclear cells (PBMCs) of psoriatic patients and healthy controls using semi-quantitative reverse transcriptase PCR. The normalized level of Id1 transcripts in psoriatic patients was about 2-fold
includes lactic acidosis, peripheral neuropathy and lipoatrophy. Class wide adverse effects to non-nucleoside reverse transcriptase inhibitors include rash and hepatotoxicity, while efavirenz has its own unique CNS…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.